En español
NIDA

NIDA Funding Strategy for Fiscal Year 2012

Revised January 2012

Mission

The mission of the National Institute on Drug Abuse (NIDA) is to lead the Nation in bringing the power of science to bear on drug abuse and addiction.

This charge has two critical components.  The first is the strategic support and conduct of research across a broad range of disciplines.  The second is ensuring the rapid and effective dissemination and use of the results of that research to significantly improve prevention, treatment and policy as it relates to drug abuse and addiction.

Funding Strategy

Funding decisions will be based primarily on programmatic priority of the Institute and scientific merit of the application.  NIDA continues to give additional consideration to first-time R01 investigators and Early Stage Investigators (by NIH definition).

Information regarding the FY 2012 NIH Fiscal Policy for Grants can be found at:

NIDA has established the following funding policy for FY 2012:

Competing Awards

NIDA may reduce competing awards from IRG recommended levels in order to increase the number of awards issued.  Consistent with NIH funding policy, NIDA will implement a 2% increase at all stipend levels for NRSA awards.

  • Inflationary increases for future year commitments are discontinued for all competing research grant awards issued in FY 2012.
  • FY 2012 awards that have already been issued will be revised to adjust the award level and future year commitments.
  • Renewal grants should not increase by more than 10% over the prior year’s direct costs.

Non-Competing Continuation Awards

Consistent with overall NIH policy every effort will be made to keep the average size of awards constant at FY 2011 levels or lower.

  • Non-competing continuation awards will be issued without cost of living/inflationary adjustments in FY 2012.
  • Inflationary increases for future year commitments are discontinued for all non-competing continuation awards issued in FY 2012.
  • FY 2012 awards that have already been issued will be revised to adjust the award level and future year commitments.
  • Modular and R13 continuation awards will be funded at FY 2011 levels, including co-funds. 
  • Non-modular continuation awards will be funded at approximately 98% of committed levels for the current year of support, including co-funds. 
  • NSRAs (Fs and Ts) will be allowed a 2% increase for stipends only.

NIDA will continue to support the:

This page was last updated January 2012

Get this Publication

    Search for Funding

    Featured Publication

    Mentoring, A Guide for Drug Abuse Researchers publication cover

    Mentoring: A Guide for Drug Abuse Researchers

    Discusses the importance of quality mentorship in drug abuse research and offers suggestions for creating a successful mentor and mentee relationship.